🔎 Trials Near Me

Home › Metastatic Cancer › California › Baldwin Park

Metastatic Cancer clinical trials in Baldwin Park, CA

30 studies for Metastatic Cancer are looking for participants at sites in and around Baldwin Park (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

RecruitingPhase 3
  • City of Hope, Duarte · 4 mi away
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT07562152

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

RecruitingPhase 1
  • City of Hope Comprehensive Cancer Center, Duarte · 4 mi away
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT05372614

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

RecruitingPhase 1
  • City of Hope National Medical Center, Duarte · 4 mi away
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06465069

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

RecruitingPhase 1
  • City of Hope Comprehensive Cancer Center, Duarte · 4 mi away
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06625775

A Study of ASP3082 in Adults With Advanced Solid Tumors

RecruitingPhase 1
  • City of Hope National Medical Center, Duarte · 4 mi away
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT05382559

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

RecruitingPhase 1
  • City of Hope Cancer Center-Duarte, Duarte · 4 mi away
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07277413

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

RecruitingPhase 2
  • City of Hope, Duarte · 4 mi away
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07007559

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

RecruitingPhase 1
  • City of Hope, Duarte · 4 mi away
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07114601

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

RecruitingPhase 3
  • City of Hope, Duarte, Duarte · 4 mi away
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07213804

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

RecruitingPhase 3
  • City of Hope, Duarte · 4 mi away
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07174336

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

RecruitingPhase 1/2
  • City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte · 4 mi away
  • City of Hope Investigational Drug Services (IDS), Duarte · 4 mi away
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07227415

A Study of KK2269 in Adult Participants With Solid Tumors

RecruitingPhase 1
  • City Of Hope National Medical Center, Duarte · 4 mi away
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT06266299

A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer

RecruitingPhase 3
  • Research Site, Duarte · 4 mi away
Ages 18 to 130 · All sexes · Updated Sep 8, 2026 · NCT07647328

Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

RecruitingPhase 2
  • City of Hope Comprehensive Cancer Center, Duarte · 4 mi away
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT06311214

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer

RecruitingPhase 1/2
  • City of Hope, Duarte · 4 mi away
Ages 18 and older · Women · Updated Sep 3, 2026 · NCT04802759

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

RecruitingPhase 1
  • City of Hope, Duarte · 4 mi away
Ages 18 and older · All sexes · Updated Aug 28, 2026 · NCT07029399

Actinium 225 Labeled Anti-CEA Antibody (Ac225-DOTA-M5A) for the Treatment of CEA Producing Advanced or Metastatic Cancers

RecruitingPhase 1
  • City of Hope Medical Center, Duarte · 4 mi away
Ages 18 and older · All sexes · Updated Aug 26, 2026 · NCT05204147

PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

RecruitingPhase 1
  • City of Hope Medical Center, Duarte · 4 mi away
Ages 18 and older · All sexes · Updated Aug 26, 2026 · NCT04329494

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

RecruitingPhase 1
  • City of Hope, Duarte · 4 mi away
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT05614739

Spatiotemporal Stereotactic Body Radiation Therapy for the Treatment of Patients With Polymetastatic Solid Tumors

RecruitingEarly phase 1
  • City of Hope Medical Center, Duarte · 4 mi away
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT05733949

Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes

RecruitingPhase 1
  • City of Hope Comprehensive Cancer Center, Duarte · 4 mi away
Ages 18 and older · All sexes · Updated Aug 3, 2026 · NCT05687110

A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors

RecruitingPhase 1/2
  • Crinetics Study Site, Duarte · 4 mi away
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT07129252

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

RecruitingPhase 1
  • City of Hope, Duarte · 4 mi away
Ages 18 and older · All sexes · Updated Jul 15, 2026 · NCT06657144

First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors

RecruitingPhase 1
  • Research Site, Duarte · 4 mi away
Ages 18 and older · All sexes · Updated Jun 12, 2026 · NCT07284186

Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

RecruitingPhase 3
  • City of Hope Medical Center, Duarte · 4 mi away
Ages 18 and older · All sexes · Updated May 18, 2026 · NCT06757634

Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)

RecruitingPhase 2
  • I-MAB Site 1005, Duarte · 4 mi away
Ages 18 and older · All sexes · Updated May 14, 2026 · NCT07432295

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

RecruitingPhase 1
  • City of Hope, Duarte · 4 mi away
Ages 18 to 75 · All sexes · Updated Mar 17, 2026 · NCT04119024

Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR)

RecruitingPhase 1
  • City of Hope Medical Center, Duarte · 4 mi away
Ages 18 and older · All sexes · Updated Jan 28, 2026 · NCT05371132

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RecruitingObservational study
  • Massive Bio SYNERGY-AI site, Duarte · 4 mi away
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

A First-in-human (FIH), Phase I Study of PTX-912 in Patients with Locally Advanced/Metastatic Solid Tumors

RecruitingPhase 1
  • City of Hope National Medical Center, Duarte · 4 mi away
Ages 18 and older · All sexes · Updated Nov 7, 2024 · NCT06190886

Metastatic Cancer trials in other cities

Other studies in Baldwin Park

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.